Efficacy and tolerability of atorvastatin/fenofibrate fixed-dose combination tablet compared with atorvastatin and fenofibrate monotherapies in patients with dyslipidemia: A 12-week, multicenter, double-blind, randomized, parallel-group study-Reference-Cited by-同舟云学术

Efficacy and tolerability of atorvastatin/fenofibrate fixed-dose combination tablet compared with atorvastatin and fenofibrate monotherapies in patients with dyslipidemia: A 12-week, multicenter, double-blind, randomized, parallel-group study

Published:2009-12 Issue:12 Volume:31 Page:2824-2838
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Davidson Michael H.,Rooney Michael W.,Drucker Joan,Eugene Griffin H.,Oosman Sonia,Beckert Michael

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference24 articles.

1. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report;Circulation,2002

2. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge;Friedewald;Clin Chem,1972

3. Reducing residual risk for patients on statin therapy: The potential role of combination therapy;Davidson;Am J Cardiol,2005

4. Reducing residual risk for patients on statin therapy: The potential role of combination therapy;Davidson;Am J Cardiol,2005

5. Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): Randomised controlled trial [published correction appears in Lancet. 2006; 368:1415, 1420];Keech;Lancet,2005

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of Statin or Fibrate Therapy on Homocysteine Concentrations: A Systematic Review and Meta-analysis;Current Medicinal Chemistry;2024-04

2. Is there still a place for fenofibrate-statin combination therapy?;European Atherosclerosis Journal;2023-12-31

3. Fixed Combination for the Treatment of Dyslipidaemia;Current Atherosclerosis Reports;2023-09-16

4. A model-agnostic framework to enhance knowledge graph-based drug combination prediction with drug–drug interaction data and supervised contrastive learning;Briefings in Bioinformatics;2023-08-07

5. Role of lipoprotein(a) in atherosclerotic cardiovascular disease: A review of current and emerging therapies;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2023-07-26